ACTRN12620000198921
Recruiting
Phase 3
SOOThe: Study of Obesity-reduction and Opiate-free Total Intravenous Anaesthesia (TIVA). Using TIVA in bariatric surgery improve the analgesia and reduce post operative nausea and vomiting.
ConditionsObesityPost operative painPost Operative Nausea and VomitingPost Operative Acute RehabilitationOpiate Free Total Intravenous AnaesthesiaAnaesthesiology - AnaestheticsAnaesthesiology - Pain managementDiet and Nutrition - ObesityRespiratory - Sleep apnoeaAnaesthesiology - Other anaesthesiology
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Obesity
- Sponsor
- Department of Anaesthesia
- Enrollment
- 130
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Elective, cognisant, adult patients booked for elective gastric reduction surgery
Exclusion Criteria
- •\[1] Patients with a history of chronic pain
- •\[2] Patients with a history of dementia or cognitive impairment
- •\[3] Patients that do not wish to consent to the study
- •\[4] Patients with a history of significant allergy or anaphylaxis to Ketamine, Propofol, Opiates and lignocaine
- •\[5] Patients who are under 16 years of age or who are above 80 years of age
- •\[6] Patients who plan not to be an inpatient for 48 hours following surgery
- •\[7] Patients with a significant history of ischaemic heart disease (IHD) who have existing arrhythmias, low left or right ejection fraction (below 40%) or raised pulmonary blood pressure
- •\[8] Patients already prescribed sodium channel blockers as part of the management of pre\-existing IHD
- •\[9] Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A clinical trial evaluating anti-obesity and antilipidemic effects of Schizandra chinensisEndocrine, nutritional and metabolic diseaseKCT0000649Dongguk University Ilsan Oriental Hospital30
Completed
Not Applicable
A study to evaluate the anti-obesity effects of continuous intake with food containing multiple ingredientsot applicableJPRN-UMIN000048605FUKUOKA KINEN PET KENSHIN CENTER80
Unknown
Phase 2
Clinical Trial on Binge Eating Disorder, Treatment With Naloxone SprayBinge Eating DisorderNCT01567670Lightlake Sinclair Ltd.138
Completed
Not Applicable
Screening and Prevention of Non Communicable Diseases (NCDs) through Schools and Community based approachCTRI/2016/09/007323Madras Diabetes Research Foundation
Not yet recruiting
Not Applicable
Investigation on the anti-obesity effects of research food intakeJPRN-UMIN000054009Metagen, Inc.20